Objective: To determine the prevalence of hemorrhagic gastro-intestinal (GI) disease developing in dogs 5 and cats admitted for management of non-GI disease in veterinary intensive care units (ICUs). 6
In human medicine, stress-related mucosal disease (SRMD) refers to the development of erosive 37 lesions of the stomach and intestines in patients admitted to ICUs for management of severe illness 1 . The 38 term covers a spectrum of disease, from superficial mucosal injury detectable only by 39 gastroduodenoscopy to severe ulceration that results in clinically important hemorrhage. Overt clinical 40 bleeding due to SRMD was reported to occur in approximately 4% of humans admitted to a group of 41 The primary aim of this study was to determine the proportion of animals that developed overt 75 hemorrhagic GI disease in veterinary ICU patients. It was hypothesized that this would occur at similar 76 rates to those reported in human ICUs, and that dogs would develop the disease more frequently than cats 77 based on previous evidence suggesting that the GI tract is not the shock organ of cats. Secondary aims 78
were to investigate risk factors for the development of hemorrhagic GI disease, and to determine whether 79 development of these signs was associated with mortality during the period of hospitalization. 80
81

Materials and Method
82
Study design A retrospective multi-center survey was conducted at three intensive care units 83 (Centers 1, 2 and 3) located in teaching hospitals in the UK. These units accept referral cases from 84 veterinarians in general practice and from other specialist services within the same institutions. Case 85 management in each unit is supervised by board certified clinicians in emergency and critical care, 86 internal medicine, surgery or neurology. Entry and egress of patients from the ICUs and use of any drugs, 87 including gastro-protectant medications, were at the discretion of the attending clinician. 88
89
All cases presenting consecutively to the ICUs were considered eligible for enrolment during the 90 period of the study if they were hospitalized for at least twenty-four hours. Cases were excluded if they 91 The proportion of veterinary patients that developed SRMD was determined by dividing the 125 number of cases with hematemesis, melena or hematochezia by the total number of included cases 126 collectively and for each ICU, and 95% confidence intervals were calculated. 127
128
Multivariable logistic regression was used to evaluate risk factors for development of SRMD and 129 for mortality during hospitalization. Univariable analyses were first conducted using Mann-Whitney U 130 tests, Chi squared tests or Fisher's exact tests, and variables with p values <0.2 were retained. These 131 variables were entered together in the multivariable analysis, and a model was fitted using a forward entry 132 method based on calculation of likelihood ratios. A categorical variable describing whether prophylactic 133 gastro-protectant medications were administered was forced into the final model for development of 134 SRMD, and a variable describing whether cases fulfilled the SIRS criteria was forced into the model of 135 mortality as these factors were considered to be of considerable a priori importance for each model based 136 on published evidence 2,16 . Institute was included as a factor in both models to account for possible 137 differences between centers. Hosmer-Lemeshow tests were performed to assess the adequacy of model 138 fit, and receiver operator characteristic (ROC) curves were produced using probabilities derived from 139 each logistic regression model to determine the predictive capability of each model. 140
141
Results
142
Study populations: After removal of duplicate cases and application of exclusion criteria, 272 143 dogs and 94 cats were included in the study (Figure 1 Table 2 . 160
161
Of the dogs that developed SRMD (n=19), the most common diagnoses were immune-mediated 162 disease (4), neoplasia (2), trauma (2), and Angiostrongylus vasorum infestation (2). The remaining dogs 163 were diagnosed with pyelonephritis (1), fasciitis (1), traumatic brain injury (1), hepatic disease (1), 164 intervertebral disc protrusion (1), hypoadrenocorticism (1), sudden acute retinal degeneration syndrome 165
(1), sepsis and disseminated intravascular coagulation (1), and intra-abdominal hemorrhage following 166 ovariohysterectomy (1) . 167
168
Feeding tubes were placed in 27 animals across all centers. Only esophagostomy tubes were 169 placed in cats (n=7), but naso-esophageal (n=12), esophagostomy (n=5) and gastrostomy (n=3) tubes 170 were placed in dogs. The majority of the tubes were placed at Center 1 (n=23), with a smaller number at Table 2 . There was no difference in duration of 193 hospitalization between cats and dogs from all centers, but average length of hospitalization was greater at 194 both Centers 2 (p=0.048) and 3 (p<0.001) compared to Center 1. Thirty-seven (13.6%) dogs and 12 195 (12.8%) cats died or were euthanized while hospitalized. Mortality rates were similar between centers 196 and species, but the proportion of dogs with SRMD that did not survive to discharge (8/19 dogs, 42.1%) Figure 2) . 210 211 Naso-esophageal feeding tubes were placed routinely in dogs that were mechanically ventilated. 212
When these animals were excluded from the analysis (n=4), the odds ratio for tube placement decreased 213 The results of this study show that hemorrhagic GI disease, defined here as SRMD, does occur in 219 dogs hospitalized in veterinary ICUs, but was not observed in any of the cats that were included. Dogs 220 with SRMD were more likely to have decreased serum concentrations of albumin on presentation, but this 221 parameter had a low sensitivity and specificity for prediction of development of this disease. Affected to have been hospitalized at Center 3. SRMD and placement of a feeding tube were significantly more 224 likely to occur in dogs that died or were euthanized while hospitalized. 225
226
The proportion of dogs that developed SRMD varied considerably between Centers, and dogs at 227
Center 3 were at significantly reduced risk compared to either Center 1 or 2. The cause of this difference 228 is not apparent: SRMD could have developed at similar rates at Centers 2 and 3 as at Center 1 but was not 229 recorded, although the authors consider this scenario to be unlikely as occurrence of all forms of GI 230 disease is considered to be a notable event among nursing staff and attending clinicians at all three 231 centers. The true prevalence of SRMD at Center 2 may also differ from that reported due to the small 232 number of cases observed in this study, as indicated by the wide confidence intervals for this parameter. 233
234
Measurable hemorrhage due to stress-related GI injury is reported to occur in approximately 4-235 6% of affected humans 2,16 , which is broadly comparable to the proportion of dogs affected with SRMD 236 defined according to this study. In contrast to human intensive care, none of the animals included in this 237 study underwent gastroduodenoscopy, which is a much more sensitive technique for detection of 238 superficial erosions in the acid-secreting sections of the stomach. When this technique was applied in 239 dogs undergoing surgery for management of inter-vertebral disc disease, subclinical lesions were 240 observed in approximately 75% of patients 7, 8 . The animals considered in this study are therefore likely to 241 represent the most severely affected patients in a spectrum of stress-related GI disease, similar to the 242 syndrome of clinically important bleeding in humans with SRMD. 243 244 SRMD was not observed in any of the 94 cats that were included in this study, and this finding is 245 consistent with the hypothesis that the GI tract is not a 'stress organ' in cats. Previous experimental 17 Observation of a greater number of cats in ICUs is likely to be required to determine whether SRMD 249 occurs at lower prevalence than could be detected during this study. 250
251
Dogs that developed SRMD were more likely to have decreased serum albumin concentrations at 252 presentation. Albumin is an essential product used in maintaining the GMB, and dogs with decreased 253 albumin concentrations are reported to be at increased risk of dehiscence following incisional biopsy of 254 the small intestine 20 . It is therefore possible that dogs with hypoalbuminemia are at increased risk of 255 SRMD and other GI signs due to their inability to maintain an effective mucosal wall. Alternatively, the 256 albumin concentration could be decreased in patients that have clinically undetectable GI injury resulting 257 in increased GI permeability and protein-losing enteropathy, prior to the onset or recognition of 258
hemorrhagic GI disease. Investigation of Alaskan sled dogs indicated that increased gastric permeability 259
was an early event in development of erosive gastric disease in this cohort 10 , suggesting that 260 hypoalbuminemia could be an effect rather than a cause of the GI signs observed. Hypoalbuminemia in 261 this study may also represent a non-specific marker of illness, as serum albumin is a negative acute phase 262
protein. Decreased serum concentrations of albumin have also been identified as negative independent 263
prognostic factors in two studies of dogs admitted to veterinary ICUs 21, 22 . 264
265
With a cut off value of 28.0 g/l (2.8 g/dl, the lower limit of the reference range in use at Center 1), 266 serum albumin concentration had a poor sensitivity and specificity for prediction of the development of 267 SRMD, limiting the usefulness of this parameter in guiding the use of prophylactic interventions. Further 268 studies will be required to establish whether patients with hypoalbuminemia would benefit from 269 administration of gastro-protectant medications. 270 for SRMD in this study probably relates to the relatively low prevalence of these problems in this sample, 286 and in veterinary ICU caseloads in the UK. 287 288 SRMD and placement of a feeding tube were significantly more likely to occur in dogs that died 289 or were euthanized compared to those that were discharged. Placement of a feeding tube is considered to 290 be a relatively benign procedure 24 and, in this group of patients, was usually performed at the same time 291 as imaging or other procedures that necessitated general anesthesia or sedation. Placement of a feeding 292 tube in this model is more likely to be a proxy variable that could represent a prolonged history of 293 anorexia or anticipated anorexia, or a patient likely to require a long period of intensive care following 294 placement. Feeding tubes were also placed in four patients in preparation for mechanical ventilation, 295 which is also likely to be a poor prognostic indicator in veterinary ICU patients 25 . The authors do not 296 Evidence from human medicine suggests that enteral nutrition should be beneficial for patients 301 with stress-related GI disease 26 , and early re-introduction of enteral feeding may reduce the requirement 302 for gastro-protectant medications. A recent pilot study of dogs with pancreatitis further indicated that 303 enteral feeding was well tolerated in critical care patients and was not associated with a greater prevalence 304 of adverse effects compared to administration of parenteral nutrition 27 , and a study of dogs with septic 305 peritonitis suggested that introduction of early enteral nutrition was associated with shorter duration of 306 hospitalization 28 . Nevertheless, it remains to be determined in future studies whether re-introduction of 307 enteral nutrition would prevent the hemorrhagic GI disease reported in patients in this study. 308
309
Development of hemorrhagic GI disease in patients that did not present for investigation or 310 management of GI disease is likely to cause increased morbidity, either due to development of anemia, 311 production and release of further inflammatory mediators, or increased risk of bacterial translocation 312 across the wall of the stomach or upper small intestine. SRMD may itself act as a proxy variable for 313 severe systemic disease, such as SIRS, sepsis, or multiple organ dysfunction syndrome (MODS). A 314 variable describing fulfilment of established SIRS criteria was included in the final model of factors 315 associated with mortality during hospitalization to try to account for this possibility as this factor was 316
shown to be significant in a previous study 15 . Despite this, development of SRMD remained an 317 independent predictor of mortality, and the higher risk of mortality among patients that developed SRMD 318 is consistent with findings in humans with overt clinical hemorrhage due to GI disease 2 . 319 but, using a clinically relevant cut off value, this variable had a poor sensitivity and specificity for 334 prediction of the disease. Development of SRMD and placement of a feeding tube were independently 335 associated with increased mortality while hospitalized, but further studies will be required to determine 336 the effects and potential benefits of prophylactic gastro-protectant therapy in veterinary ICU patients. 
